Project Grant H79TI088972
- The Department of Health and Human Services Health Resources and Services Administration awarded $650,000 to MC Dermott Center Inc., doing business as Haymarket Center, on August 1, 2026, under the Health Center Program (CFDA 93.224). Haymarket Center will expand primary health care services to individuals experiencing homelessness and untreated medical and behavioral health conditions through its New Access Points (NAP) Project. The funding will support expansion to serve 3,500 new patients,...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded Heartland Family Service $524,995 on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) to deliver residential treatment, recovery services, and case management for pregnant and postpartum women with substance use disorders and co-occurring mental health disorders across Nebraska and Iowa. The Family...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded $749,962 to The University of Chicago Medical Center on September 30, 2026, under the Center for Mental Health Services Projects of Regional and National Significance program (CFDA 93.532) to build and operate a cross-sector alliance delivering behavioral health prevention and intervention services to youth in Chicago's Far South Side communities. The recipient will connect at-risk youth...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded the Illinois Department of Human Services $7.190 million on September 30, 2025, under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) to reduce youth substance use on the South and West Sides of Chicago through the Strategic Prevention Framework—Partnerships for Success project. The Illinois SPF-PFS project implements...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded The Johns Hopkins University $525,000 on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) to deliver comprehensive substance use disorder treatment and recovery support to pregnant and postpartum women and their minor children through the ANCHOR initiative. ANCHOR pairs Johns Hopkins' Comprehensive...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded Endeavor Health Clinical Operations, doing business as Evanston Hospital, $989,566 under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) on September 30, 2026, to implement screening, brief intervention, and referral to treatment (SBIRT) across healthcare settings in Cook and Lake Counties, Illinois. The Community...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded Annie Malone Children & Family Service Center $545,000 on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490). The SAFER2 project will deliver integrated, family-centered prevention, treatment, and recovery support services for children, adolescents, young adults, and their primary caregivers affected...
- The Substance Abuse and Mental Health Services Administration awarded Family Ark, Inc. $524,432 on September 30, 2026, to expand family-centered substance use disorder treatment for pregnant, postpartum, and parenting women in southern Indiana under the Center for Substance Abuse Treatment Projects of Regional and National Significance program. Family Ark will implement ASAM Level 3.5 clinically managed high-intensity residential treatment integrated with existing outpatient, intensive...
- The Substance Abuse and Mental Health Services Administration awarded The Women's Home $1.5 million under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) on September 30, 2025, to expand its Passages Intensive Outpatient Program for women with substance use and co-occurring mental health disorders. The Women's Home will establish a second IOP site in the Spring Branch East neighborhood of Northwest Houston, Texas, delivering...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded the Chicago Recovering Communities Coalition (CRCC) $350,000 on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490). CRCC will expand peer recovery support services (PRSS), professionalize the peer workforce, and implement recovery-ready workplace infrastructure across five high-burden West Side Chicago...
The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded MC Dermott Center Inc., doing business as Haymarket Center, $525,000 on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490). Haymarket Center will deliver comprehensive, integrated behavioral health and primary care services to 119 pregnant and postpartum women with substance use disorders and their 48 children in a residential treatment setting. The program targets Cook County, Illinois with focus on communities with higher prevalence of substance use disorder. Year 1 enrollment includes 19 women and 8 children, scaling to 25 women and 10 children annually in Years 2–5. The adult population will be 100 percent female with a median age of 35; children will range from newborns to 6 years old. At admission, 89 percent of participants will be unstably housed and 94 percent unemployed; 30 percent will have criminal justice involvement. All adult participants will have substance use disorder and likely co-occurring mental health disorders or serious mental illness. Measurable objectives include providing FDA-approved medication to 95 percent of women who choose this treatment and connecting 95 percent of women to recovery housing and wraparound services. The program seeks to identify and engage participants, improve access to evidence-based practices, promote long-term recovery, and strengthen sustained recovery post-treatment. The award period runs from September 30, 2026, through September 29, 2031. Place of performance is Chicago, Illinois 60607.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $525.0k | 9/2/26 |